1. Home
  2. SVRA vs CMP Comparison

SVRA vs CMP Comparison

Compare SVRA & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • CMP
  • Stock Information
  • Founded
  • SVRA N/A
  • CMP 1993
  • Country
  • SVRA United States
  • CMP United States
  • Employees
  • SVRA N/A
  • CMP N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • SVRA Health Care
  • CMP Basic Materials
  • Exchange
  • SVRA Nasdaq
  • CMP Nasdaq
  • Market Cap
  • SVRA 540.6M
  • CMP 514.0M
  • IPO Year
  • SVRA N/A
  • CMP 2003
  • Fundamental
  • Price
  • SVRA $2.80
  • CMP $13.87
  • Analyst Decision
  • SVRA Buy
  • CMP Buy
  • Analyst Count
  • SVRA 7
  • CMP 3
  • Target Price
  • SVRA $9.86
  • CMP $20.67
  • AVG Volume (30 Days)
  • SVRA 966.0K
  • CMP 656.0K
  • Earning Date
  • SVRA 03-06-2025
  • CMP 02-05-2025
  • Dividend Yield
  • SVRA N/A
  • CMP 1.08%
  • EPS Growth
  • SVRA N/A
  • CMP N/A
  • EPS
  • SVRA N/A
  • CMP N/A
  • Revenue
  • SVRA N/A
  • CMP $1,117,400,000.00
  • Revenue This Year
  • SVRA N/A
  • CMP $4.62
  • Revenue Next Year
  • SVRA N/A
  • CMP $7.36
  • P/E Ratio
  • SVRA N/A
  • CMP N/A
  • Revenue Growth
  • SVRA N/A
  • CMP N/A
  • 52 Week Low
  • SVRA $2.60
  • CMP $7.51
  • 52 Week High
  • SVRA $5.70
  • CMP $23.99
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 39.71
  • CMP 64.07
  • Support Level
  • SVRA $2.60
  • CMP $13.01
  • Resistance Level
  • SVRA $3.14
  • CMP $11.49
  • Average True Range (ATR)
  • SVRA 0.17
  • CMP 0.68
  • MACD
  • SVRA -0.01
  • CMP 0.38
  • Stochastic Oscillator
  • SVRA 32.79
  • CMP 86.47

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Canada, the us state of Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: